ABSTRACT
The expression of the HER2 (human epidermal growth factor receptor 2) protein in cancer cells is a well-established cancer marker used for diagnostic and therapeutic purposes in modern treatment protocols, especially in breast cancer. The gold-standard immunohistochemical diagnostic methods with the specific anti-HER2 antibodies are utilized in the clinic to measure expression level of the membrane-bound receptor. However, a soluble extracellular domain (ECD) of HER2 is released to the extracellular matrix, thus the blood assays for HER2 measurements present an attractive way for HER2 level determination. There is a need for accurate and validated assays that can be used to correlate the concentration of the circulating HER2 protein with disease clinical manifestations. Here we describe two monoclonal antibodies binding HER2 with a unique sequence of the complementarity-determining regions that recognize HER2 ECD. Development and validation of the sandwich enzyme-linked immunosorbent assay (ELISA) for quantification of the soluble HER2 in a variety of biological samples is also presented. The assay provides HER2 quantitation within a concentrations range from 1.56 to 100 ng/ml with sensitivity at the level of 0.5 ng/ml that meets the expectations for measurements of HER2 in the blood and tumor tissue samples. The method presents satisfactory intra- and inter-assay precision and accuracy for immunochemical quantification of biomarkers in biological samples. The utility of the generated monoclonal anti-HER2 antibodies has been confirmed for use in the precise measurement of HER2 (both cell-bound and soluble) in several types of biological material, including serum, solid tumor tissue, and cell culture medium. Additionally, the developed immunochemical tools have a potential for HER2 detection, not only in a wide range of sample types but also independently of the sample storage/pre-processing, allowing for comprehensive HER2 analysis in tissue (IHC), cultured cells (immunofluorescence) and blood (ELISA).
Subject(s)
Antibodies, Monoclonal , Breast Neoplasms , Humans , Female , Antibodies, Monoclonal/therapeutic use , Receptor, ErbB-2 , Breast Neoplasms/metabolism , Enzyme-Linked Immunosorbent Assay/methods , Cells, Cultured , Biomarkers, TumorABSTRACT
Aluminum-silicon alloys require modification due to their coarse-grained microstructures and resulting low strength properties. So far, research into the modification process has focused on the use of various chemical components and technological processes, the tasks of which are to refine the microstructure and, thus, increase the mechanical properties of the alloy. In this paper, the answer to the question of whether the form of the modifier influences the modification effect of the hypoeutectic silumin will be found. The tests were carried out using the popular silumin AlSi7Mg. To answer our research question, the alloy was modified under comparable conditions using the following elements: Ti, B, and master alloys AlTi1.5 and AlB1.5. Modifiers in the form of Sr and master alloy AlSr1.5 were also used. All mentioned modifiers were produced and introduced into the liquid alloy in the form of a powder and a rod. Master alloys AlSr1.5 were also produced via cooling from the liquid state through cooling in air and the second variant at a speed of 200 °C/s (in the form of powder and a thin strip). The microstructure and mechanical properties were analyzed based on the following measures: tensile strength, elongation, and hardness of silumin. Based on the conducted research, it was found that the form of the modifier also affects the modification effect visible in the form of changes in the microstructure and mechanical properties. For the powder-modified alloy, greater fineness in the eutectic phase (α and B phases) and an increase in all analyzed mechanical properties were obtained.
ABSTRACT
One of the main parameters characterizing steel is tensile strength. Conducting actual research is time consuming and expensive. For this reason, the technique uses simplified methods that allow one to quickly estimate the resistance of the material to fatigue. They are conducted mainly by computer methods. For the proper development of programs to determine the fatigue parameters of steel, solid data preparation is necessary. Unfortunately, some studies are performed on materials produced in laboratory conditions, which is only an approximation of the actual production conditions. Real alloys contain natural impurities which can affect their properties. Therefore, it is important to use real results obtained on an industrial scale for analysis including computer simulations. One of the important parameters that can be used to describe the properties of steel is the scatter index. It is the quotient of the average distance between the pollution and the average size of the pollution. This parameter makes it possible to take into account the fatigue strength of steel, taking into account the size of impurities and the distance between these impurities. The paper attempted to determine the scatter index and its impact on the fatigue resistance coefficient for steel melted in an industrial 140 ton electric furnace. The tests were carried out on structural steel with an average carbon content of 0.26%. The steel was hardened and tempered in all temperature tempering ranges (low, medium, and high). The fatigue resistance coefficient in the scatter index function was determined and discussed for each of the applied heat treatment parameters.
ABSTRACT
In the course of evolution, humankind has used many construction materials [...].
ABSTRACT
Viral infection activates the innate immune system, which recognizes viral components by a variety of pattern recognition receptors and initiates signalling cascades leading to the production of pro-inflammatory cytokines. To date, signalling cascades triggered after virus recognition are not fully characterized and are investigated by many research groups. The critical role of the E3 ubiquitin ligase Pellino3 in antibacterial and antiviral response is now widely accepted, but the precise mechanism remains elusive. In this study, we sought to explore Pellino3 role in the retinoic acid-inducible gene I (RIG-I)-dependent signalling pathway. In this work, the molecular mechanisms of the innate immune response, regulated by Pellino3, were investigated in lung epithelial cells during influenza B virus infection. We used wild-type and Pellino3-deficient A549 cells as model cell lines to examine the role of Pellino3 ligase in the type I interferon (IFN) signalling pathway. Our results indicate that Pellino3 is involved in direct ubiquitination and degradation of the TRAF3, suppressing interferon regulatory factor 3 (IRF3) activation and interferon beta (IFNß) production.
Subject(s)
Influenza, Human , TNF Receptor-Associated Factor 3 , Humans , TNF Receptor-Associated Factor 3/genetics , TNF Receptor-Associated Factor 3/metabolism , Interferon Regulatory Factor-3/genetics , Interferon Regulatory Factor-3/metabolism , Down-Regulation , Immunity, Innate , Ubiquitin-Protein Ligases/genetics , Ubiquitin-Protein Ligases/metabolismABSTRACT
Bacteriophages (phages) are viruses infecting bacteria. They are widely present in the environment, food, and normal microflora. The human microbiome is a mutually interdependent network of bacteria, bacteriophages, and human cells. The stability of these tri-kingdom interactions may be essential for maintaining immunologic and metabolic health. Phages, as with each other's antigens, may evoke an immune response during a human's lifetime and induce specific antibody generation. In this manuscript, we labeled these antibodies as naturally generated. Naturally generated antibodies may be one of the most important factors limiting the efficacy of phage therapy. Herein, we attempted to determine the physiological level of these antibodies specific to a population bacteriophage named I11mO19 in human sera, using an ELISA-based assay. First, we purified the phage particles and assessed the immunoreactivity of phage proteins. Then, affinity chromatography was performed on columns with immobilized phage proteins to obtain a fraction of human polyclonal anti-phage antibodies. These antibodies were used as a reference to elaborate an immunoenzymatic test that was used to determine the level of natural anti-phage antibodies. We estimated the average level of anti-I11mO19 phage antibodies at 190 µg per one milliliter of human serum. However, immunoblotting revealed that cross-reactivity occurs between some proteins of I11mO19 and two other coliphages: T4 and ΦK1E. The antigens probably share common epitopes, suggesting that the determined level of anti-I11mO19 phage might be overestimated and reflects a group of antibodies reactive to a broad range of other E. coli phages. Anti-I11mO19 antibodies did not react with Pseudomonas bacteriophage F8, confirming specificity to the coliphage group. In this work, we wanted to show whether it is possible to determine the presence and level of anti-phage antibodies in nontargeted-immunized sera, using an immunoenzymatic assay. The conclusion is that it is possible, and specific antibodies can be determined. However, the specificity refers to a broader coliphage group of phages, not only the single phage strain.
ABSTRACT
IFN-I is the key regulatory component activating and modulating the response of innate and adaptive immune system to bacterial as well as viral pathogens. IFN-I promotes the expression of IFN-induced genes (ISG) and, consequently, the production of chemokines, e.g., CXCL10. Those chemokines control migration and localization of immune cells in tissues, and, thus, are critical to the function of the innate immune system during infection. Consequently, the regulation of IFN-I signaling is essential for the proper induction of an immune response. Our previous study has shown that E3 ubiquitin ligase Pellino3 positively regulates IFNß expression and secretion. Herein, we examined the role of Pellino3 ligase in regulating CXCL10 expression in response to IFNß stimulation. Our experiments were carried out on murine macrophage cell line (BMDM) and human monocytes cell line (THP-1) using IFNß as a IFNAR ligand. We demonstrate that Pellino3 is important for IFNß-induced phosphorylation and nuclear translocation of STAT1/STAT2/IRF9 complex which interacts with CXCL10 promoter and enhances its expression. In this study, we characterize a novel molecular mechanism allowing Pellino3-dependent modulation of the IFNß-induced response in BMDM and THP-1 cell lines.
Subject(s)
Chemokine CXCL10 , Interferon Type I , Animals , Humans , Mice , Chemokine CXCL10/genetics , Chemokine CXCL10/metabolism , Interferon Type I/metabolism , Ligases/metabolism , Macrophages/metabolism , Monocytes/metabolism , Signal Transduction , Interferon-beta/pharmacologyABSTRACT
Non-metallic inclusions are one of the many factors influencing the strength of materials operating under variable loads. Their influence on the strength of the material depends not only on the morphology of the impurities themselves, but it is also closely related to the microstructure of the material. This microstructure is the matrix for non-metallic inclusions. This article discusses the results of a study investigating the effect of non-metallic inclusions on the fatigue strength of structural steel during rotary bending. The study was performed at 12 heats produced in an industrial plant's 140-ton electric furnaces. Six heats were desulphurised, and six were refined with argon. This paper presents the bending fatigue strength of steel hardened and tempered at different temperatures, subject to the relative volume of inclusions. This paper also presents the dimensional structure of non-metallic inclusions divided by different two technologies. The research shows that the main fraction of non-metallic inclusions is Al2O3; the most numerous were impurities with a diameter of less than 2 µm; argon refining does not affect the proportion of non-metallic inclusions of large dimensions (with a diameter of over 15 µm); the influence of non-metallic inclusions on the strength of the steel is also related to the microstructure of the steel constituting the matrix of inclusions.
ABSTRACT
Sensing of viral particles and elements that initiate mechanisms of immune response is an intrinsic ability of mammalian cells. Regulatory cytokines and antiviral mediators are released after triggering of complex signaling cascades in response to interaction of pathogen particles with pattern recognition receptors (PRRs) leading to the production of interferons (IFN) and proinflammatory cytokines. Viral RNA in the cytoplasm constitute a potent danger molecule that recognition is performed by RIG-I-like receptors, the most common group of receptors in mammalian cells, capable to recognize a foreign RNA. It is known that the E3 ubiquitin ligase Pellino3 plays an important role in antibacterial and antiviral response, but its involvement in the RLR pathways remains poorly understood. In this study, we investigate the molecular mechanisms of the innate immune response in BMDMs (immortalized macrophages from mouse bone marrow) during VSV infection. Here, we present evidence that the activation of the RIG-I/Pellino3/ERK1/2 pathway in BMDMs is crucial for the protection against VSV. We demonstrate that during infection, viral particles replicate in Pellino3 knockout BMDMs more effectively than in wild-type cells. Increased viral replication resulting in cell lysis and death is aid by impaired synthesis of IFN-I and inflammatory cytokines as a consequence of disturbances in the ERK1/2 pathway regulation.
Subject(s)
Immunity, Innate/immunology , Macrophage Activation/immunology , Macrophages/metabolism , Ubiquitin-Protein Ligases/metabolism , Animals , Cytokines/metabolism , Immunity, Innate/genetics , Interferons/metabolism , Macrophage Activation/physiology , Mice , RNA, Viral/metabolism , Signal Transduction/genetics , Signal Transduction/immunology , Virus Replication/immunologyABSTRACT
This study reports a novel impedimetric immunosensor for protein D detection in purified and bacterial (Haemophilus influenzae, Hi) samples. The detection was based on antigen recognition by anti-protein D antibodies (apD) immobilised at the maze-like boron-doped carbon nanowall electrodes (B:CNW). The B:CNW electrodes were synthesised, and their surface was characterised by scanning electron microscopy (SEM) and X-ray photoelectron spectroscopy (XPS) methods. The sensor was prepared in a two-step procedure: apD were covalently linked on the previously modified B:CNW electrodes using diazonium salt. Modification steps were controlled by electrochemical impedance spectroscopy (EIS) and cyclic voltammetry (CV) measurements. The immunosensor exhibited excellent electrochemical performance, stability, satisfactory sensitivities, and linear ranges for antigen detection. Protein D was detected down to 2.39 × 102fg/mL with a linear range extending from 3.37 × 10-11to 3.37 × 10-3µg/mL (in purified sample). Next, Hi's LOD was 5.20 × 102CFU/mL with a linear range of 8.39 × 101-8.39 × 103CFU/mL. Selectivity studies showed no reaction with negative samples as Streptococcus pyogenes, Streptococcus pneumoniae or Bordetella parapertussis bacteria. Therefore, the new approach is suitable for rapid and quantitative detection of Hi, and is a good candidate for further tests on clinical samples.
Subject(s)
Biosensing Techniques , Boron , Carbon , Dielectric Spectroscopy , Electrochemical Techniques , Electrodes , Haemophilus influenzae , Immunoassay , Limit of DetectionABSTRACT
Activation of TLR7 by small imidazoquinoline molecules such as R848 or R837 initiates signaling cascades leading to the activation of transcription factors, such as AP-1, NF-κB, and interferon regulatory factors (IRFs) and afterward to the induction of cytokines and anti-viral Type I IFNs. In general, TLRs mediate these effects by utilizing different intracellular signaling molecules, one of them is Mal. Mal is a protein closely related to the antibacterial response, and its role in the TLR7 pathways remains poorly understood. In this study, we show that Mal determines the expression and secretion of IFNß following activation of TLR7, a receptor that recognizes ssRNA and imidazoquinolines. Moreover, we observed that R848 induces Mal-dependent IFNß production via ERK1/2 activation as well as the transcription factor IRF7 activation. Although activation of TLR7 leads to NF-κB-dependent expression of IRF7, this process is independent of Mal. We also demonstrate that secretion of IFNß regulated by TLR7 and Mal in macrophages and dendritic cells leads to the IP-10 chemokine expression. In conclusion, our data demonstrate that Mal is a critical regulator of the imidazoquinolinones-dependent IFNß production via ERK1/2/IRF7 signaling cascade which brings us closer to understanding the molecular mechanism's regulation of innate immune response.
Subject(s)
Interferon Regulatory Factor-7/genetics , Interferon-beta/genetics , Membrane Glycoproteins/genetics , Myelin and Lymphocyte-Associated Proteolipid Proteins/genetics , Toll-Like Receptor 7/genetics , Animals , Cytokines/genetics , Humans , Immunity, Innate/genetics , Interferon Type I/genetics , MAP Kinase Signaling System/genetics , Mice , Mice, Knockout , NF-kappa B/genetics , Quinolones/toxicity , Transcription Factor AP-1/geneticsABSTRACT
Advanced biodetection and bioimaging require fluorescent labels which exhibit many, easily distinguishable colors to identify or study numerous biotargets in a single sample. Although numerous different colors have been demonstrated with lanthanide doped nanoparticles, these colors usually originate from various ratios of overlapping multiple emission bands from activators, which severely limits the number of available labels. As a consequence, different lanthanide doped labels cannot be easily distinguished from each other (e.g. Er3+ from Ho3+) in a quantitative way, when such labels are co-localized during microscopy wide-field imaging. It is therefore reasonable to expand the available choice of spectral signatures and not rely on just different colors. Other ions, such as Tb3+ or Eu3+, can offer new possibilities and unique spectral features in upconversion mode in this respect. For example, despite partial overlap with Er3+ or Ho3+ emission spectra, Tb3+ ions display also unique and easily distinguishable spectral features at 580 nm. Unfortunately, in terms of brightness, Tb3+ emission in upconversion mode is typically too weak to be useful. To improve the Tb3+ upconversion emission intensity, a new approach, i.e. Mn2+ co-doping, has been proposed and verified in this work. A versatile optimization of Tb3+, Yb3+ and Mn2+ ion concentrations has been performed based on luminescence spectra and lifetime studies. The most intense emission was achieved for nanoparticles doped with 10% Mn2+ ions, with over 30 times brighter intensity of Tb3+ ions compared to the emission of nanocrystals without the addition of Mn2+ ions. Additionally, as a proof of the concept, the surface of nanoparticles was coated with proteins and conjugated with folic acid, and such biofunctionalized nanoparticles were subsequently used for bioimaging of HeLa cells.
ABSTRACT
Monoclonal antibodies (mAbs) are biomolecules of great scientific and practical significance. In contrast to polyclonal antibodies from immune sera, they are homogeneous and monospecific, since they are produced by hybridoma cells representing a clone arising from a single cell. The successful technology was described for the first time in 1975; the inventors were later awarded the Nobel Prize. Currently, mAbs are broadly used as a research tool, in diagnostics and medicine in particular for the treatment of cancer or in transplantology. About 47 therapeutics based on monoclonal antibodies are now available in the US and Europe, and the number is still growing. Production of monoclonal antibodies is a multistage, time-consuming and costly process. Growing demand for these molecules creates space for research focused on improvements in hybridoma technology. Lower costs, human labor, and time are important goals of these attempts. In this article, a brief review of current methods and their advances is given.
Subject(s)
Antibodies, Monoclonal/immunology , Antibody Formation/immunology , Antibody-Producing Cells/metabolism , Hybridomas , Antibodies, Monoclonal/metabolism , Antibodies, Monoclonal/therapeutic use , Europe , Humans , Hybridomas/cytology , Hybridomas/immunology , Hybridomas/metabolism , Neoplasms/drug therapyABSTRACT
Conjugation of synthetic oligosaccharides and native polysaccharides to proteins is an important tool in glycobiology to create vaccines and antigens to screen lectins, toxins, and antibodies. A novel approach to potentiate and profile the immune response to vaccines involves targeting antigens directly to dendritic cells (DCs), the key cells engaged in the immunization process. Inclusion of a carbohydrate ligand recognized by C-type lectins expressed on their cell surface ensures targeting of vaccines to DCs and improved immunological responses. Here we describe a strategy that permits three sequential orthogonal conjugation reactions to prepare glycoconjugates and apply them to the synthesis of a conjugate vaccine that is targeted for uptake by DCs. The carrier protein is treated with an azo-transfer reagent to convert accessible amino groups to azide and then amide bond formation via reaction with carboxylic acid side chains is used to attach amino tether groups of a ligand to the protein. Azide-alkyne Huisgen cycloaddition conjugation, "click chemistry" is used to attach a second ligand equipped with a propargyl group or an analogous terminal alkyne, and following reduction of protein azide groups back to amine, these amino acid side chains can be subjected to amide formation such as reaction with succinimide esters or homobifunctional coupling reagents such as dialkyl squarate.
Subject(s)
Amino Acids/chemistry , Azides/chemistry , Glycoconjugates/chemistry , Vaccines/chemistry , Alkynes/chemistry , Amides/chemistry , Carboxylic Acids/chemistry , Click Chemistry/methods , Cycloaddition Reaction/methods , Dendritic Cells , Indicators and Reagents/chemistry , Lectins, C-Type/chemistry , Ligands , Oligosaccharides/chemistry , Polysaccharides/chemistry , Proteins/chemistryABSTRACT
Lipopolysaccharide (LPS), the major component of the outer membrane of Gram-negative bacteria, contains the O-polysaccharide, which is important to classify bacteria into different O-serological types within species. The O-polysaccharides of serotypes O24 and O56 of E. coli contain sialic acid in their structures, already established in our previous studies. Here, we report the isolation of specific antibodies with affinity chromatography using immobilized lipopolysaccharides. Next, we evaluated the reactivity of anti-O24 and anti-O56 antibody on human tissues histologically. The study was conducted under the assumption that the sialic acid based molecular identity of bacterial and tissue structures provides not only an understanding of the mimicry-based bacterial pathogenicity. Cross-reacting antibodies could be used to recognize specific human tissues depending on their histogenesis and differentiation, which might be useful for diagnostic purposes. The results indicate that various human tissues are recognized by anti-O24 and anti-O56 antibodies. Interestingly, only a single specific reactivity could be found in the anti-O56 antibody preparation. Several tissues studied were not reactive with either antibody, thus proving that the presence of cross-reactive antigens was tissue specific. In general, O56 antibody performed better than O24 in staining epithelial and nervous tissues. Positive staining was observed for both normal (ganglia) and tumor tissue (ganglioneuroma). Epithelial tissue showed positive staining, but an epitope recognized by O56 antibody should be considered as a marker of glandular epithelium. The reason is that malignant glandular tumor and its metastasis are stained, and also epithelium of renal tubules and glandular structures of the thyroid gland are stained. Stratified epithelium such as that of skin is definitely not stained. Therefore, the most relevant observation is that the epitope recognized by anti-O56 antibodies is a new marker specific for glandular epithelium and nervous tissue. Further studies should be performed to determine the structure of the tissue epitope recognized.
Subject(s)
Antibodies/immunology , Epitopes/analysis , Escherichia coli/immunology , Immunohistochemistry , O Antigens/immunology , Staining and Labeling , Adenocarcinoma/pathology , Animals , Carbohydrate Sequence , Colon/pathology , Colon/ultrastructure , Colonic Neoplasms/pathology , Epithelium/pathology , Epithelium/ultrastructure , Epitopes/immunology , Escherichia coli/chemistry , Ganglia/pathology , Ganglia/ultrastructure , Ganglioneuroma/pathology , Humans , Kidney/pathology , Kidney/ultrastructure , Liver/pathology , Liver/ultrastructure , Liver Neoplasms/secondary , Molecular Sequence Data , O Antigens/chemistry , Rabbits , Thyroid Gland/pathology , Thyroid Gland/ultrastructureABSTRACT
Selective strategies for the construction of novel three component glycoconjugate vaccines presenting Candida albicans cell wall glycan (ß-1,2 mannoside) and polypeptide fragments on a tetanus toxoid carrier are described. The first of two conjugation strategies employed peptides bearing an N-terminal thiopropionyl residue for conjugation to a trisaccharide equipped with an acrylate linker and a C-terminal S-acetyl thioglycolyl moiety for subsequent linking of neoglycopeptide to bromoacetylated tetanus toxoid. Michael addition of acrylate trisaccharides to peptide thiol under mildly basic conditions gave a mixture of N- and C- terminal glyco-peptide thioethers. An adaptation of this strategy coordinated S-acyl protection with anticipated thioester exchange equilibria. This furnished a single chemically defined fully synthetic neoglycopeptide conjugate that could be anchored to a tetanus toxoid carrier and avoids the introduction of exogenous antigenic groups. The second strategy retained the N-terminal thiopropionyl residue but replaced the C-terminal S-acetate functionality with an azido group that allowed efficient, selective formation of neoglycopeptide thioethers and subsequent conjugation of these with propargylated tetanus toxoid, but introduced potentially antigenic triazole linkages.
Subject(s)
Epitopes, T-Lymphocyte/immunology , Fungal Vaccines/chemistry , Fungal Vaccines/chemical synthesis , Glycopeptides/chemistry , Mannosides/chemistry , Tetanus Toxoid/chemistry , Tetanus Toxoid/chemical synthesis , Acylation , Candida albicans/immunology , Chemistry Techniques, Synthetic , Sulfhydryl Compounds/chemistry , Trisaccharides/chemistry , Vaccines, Conjugate/chemistryABSTRACT
Lanthanide doped nanoparticles (Ln:NPs) hold promise as novel luminescent probes for numerous applications in nanobiophotonics. Despite excellent photostability, narrowband photoluminescence, efficient anti-Stokes emission and long luminescence lifetimes, which are needed to meet the requirements of multiplexed and background free detection at prolonged observation times, concern about their toxicity is still an issue for both in vivo and in vitro applications. Similar to other chemicals or pharmaceuticals, the very same properties that are desirable and potentially useful from a biomedical perspective can also give rise to unexpected and hazardous toxicities. In engineered bionanomaterials, the potentially harmful effects may originate not only from their chemical composition but also from their small size. The latter property enables the nanoparticles to bypass the biological barriers, thus allowing deep tissue penetration and the accumulation of the nanoparticles in a number of organs. In addition, nanoparticles are known to possess high surface chemical reactivity as well as a large surface-to-volume ratio, which may seriously affect their biocompatibility. Herein we survey the underlying mechanisms of nanotoxicity and provide an overview on the nanotoxicity of lanthanides and of upconverting nanoparticles.
Subject(s)
Nanoparticles/chemistry , Blood-Brain Barrier/metabolism , Cell Survival/drug effects , Government Regulation , Humans , Lanthanoid Series Elements/chemistry , Nanoparticles/metabolism , Nanoparticles/toxicity , Reactive Oxygen Species/metabolism , Surface PropertiesABSTRACT
In a previous attempt to generate a protective vaccine against Candida albicans, a ß-mannan tetanus toxoid conjugate showed poor immunogenicity in mice. To improve the specific activation toward the fungal pathogen, we aimed to target Dectin-1, a pattern-recognition receptor expressed on monocytes, macrophages, and dendritic cells. Laminarin, a ß-glucan ligand of Dectin-1, was incorporated into the original ß-mannan tetanus toxoid conjugate providing a tricomponent conjugate vaccine. A macrophage cell line expressing Dectin-1 was employed to show binding and activation of Dectin-1 signal transduction pathway by the ß-glucan-containing vaccine. Ligand binding to Dectin-1 resulted in the following: 1) activation of Src family kinases and Syk revealed by their recruitment and phosphorylation in the vicinity of bound conjugate and 2) translocation of NF-κB to the nucleus. Treatment of immature bone marrow-derived dendritic cells (BMDCs) with tricomponent or control vaccine confirmed that the ß-glucan-containing vaccine exerted its enhanced activity by virtue of dendritic cell targeting and uptake. Immature primary cells stimulated by the tricomponent vaccine, but not the ß-mannan tetanus toxoid vaccine, showed activation of BMDCs. Moreover, treated BMDCs secreted increased levels of several cytokines, including TGF-ß and IL-6, which are known activators of Th17 cells. Immunization of mice with the novel type of vaccine resulted in improved immune response manifested by high titers of Ab recognizing C. albicans ß-mannan Ag. Vaccine containing laminarin also affected distribution of IgG subclasses, showing that vaccine targeting to Dectin-1 receptor can benefit from augmentation and immunomodulation of the immune response.
Subject(s)
Dendritic Cells/metabolism , Drug Delivery Systems , Lectins, C-Type/administration & dosage , Tetanus Toxoid/administration & dosage , Tetanus Toxoid/immunology , beta-Glucans/metabolism , Animals , Binding Sites/immunology , Cell Line , Dendritic Cells/immunology , Drug Delivery Systems/methods , Epitopes/immunology , Epitopes/metabolism , Glucans , Lectins, C-Type/metabolism , Mice , Mice, Inbred BALB C , Mice, Inbred C57BL , Polysaccharides/immunology , Polysaccharides/metabolism , Tetanus Toxoid/metabolism , Trisaccharides/administration & dosage , Trisaccharides/immunology , Trisaccharides/metabolism , Vaccines, Conjugate/administration & dosage , Vaccines, Conjugate/immunology , Vaccines, Conjugate/metabolism , beta-Glucans/immunologyABSTRACT
A ß-(1 â 2)-linked mannose trisaccharide epitope that is the optimal inhibitor of two protective monoclonal antibodies specific for the Candida albicans cell wall phosphomannan was used to create a synthetic conjugate vaccine. Two injections of the trisaccharide-tetanus toxoid conjugate administered with alum induced a robust secondary antibody response in rabbits with trisaccharide specific IgG ELISA titers in excess of 1:100,000. Fluorescent labeling studies demonstrated these antibodies (i) recognized the cell wall ß-mannan of C. albicans on hyphae and budding cells and (ii) C. albicans incubated with immune sera bound complement factor C3. The synthetic conjugate vaccine but not the carrier protein, tetanus toxoid reduced Candida load in vaccinated rabbits subsequently rendered leukocytopenic by injection of cyclophosphamide and then challenged with live C. albicans. These data support the contention that antibody mediated immunity plays a role in combating C. albicans infections and suggests that a surprisingly simple, readily accessible synthetic conjugate vaccine may have therapeutic potential.